ATN-161 in Advanced Renal Cell Cancer

A Phase I/II Study to Assess the Safety and Efficacy of TKI258 for the Treatment of Refractory Advanced/Metastatic Renal Cell Cancer

NCT00715182 ·Status: COMPLETED ·Phase: PHASE1

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

NCT02639182 ·Status: COMPLETED ·Phase: PHASE2

Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma

NCT03117309 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma

NCT00073125 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare Treatments for a Type of Kidney Cancer Called TFE/Translocation Renal Cell Carcinoma (tRCC)

NCT03595124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC

NCT03341845 ·Status: UNKNOWN ·Phase: PHASE2

Study of CP-461 in Patients With Advanced Renal Cell Cancer

NCT00036036 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

NCT02002312 ·Status: COMPLETED ·Phase: PHASE2

A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT05119335 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC)

NCT00569946 ·Status: COMPLETED ·Phase: PHASE2

Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma

NCT03172754 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Sequential Therapy in Metastatic Renal Cell Carinoma

NCT01731158 ·Status: COMPLETED ·Phase: PHASE2

Retrospective Observational Study To Update 5-Year Survival Of Subjects Who Participated In Axitinib Trial A4061012

NCT01056263 ·Status: COMPLETED

Investigating Patient Satisfaction With Oral Anti-Cancer Treatment

NCT02247583 ·Status: COMPLETED

Cediranib Maleate in Treating Patients With Recurrent or Metastatic Kidney Cancer That Cannot Be Removed By Surgery

NCT00227760 ·Status: COMPLETED ·Phase: PHASE2

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

NCT04375150 ·Status: COMPLETED

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

NCT00920816 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study of 6MW3211 in Patients With Renal Cancer

NCT05440045 ·Status: UNKNOWN ·Phase: PHASE2

A Subject Treatment Preference Study of Tivozanib Versus Sunitinib in Subjects With Metastatic RCC

NCT01673386 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma

NCT00494091 ·Status: COMPLETED ·Phase: PHASE2

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

NCT00678119 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma

NCT01351571 ·Status: COMPLETED

A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer

NCT01114230 ·Status: COMPLETED ·Phase: PHASE1

A Research Study for Patients With Metastatic Renal Cell Carcinoma

NCT00106613 ·Status: COMPLETED ·Phase: PHASE2

Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing

NCT03109015 ·Status: COMPLETED ·Phase: PHASE2